Anti-Arrhythmia Agent

There are drug-drug interactions between the COVID-19 treatment ritonavir/nirmatrelvir and various classes of commonly used CV medications, according to a review paper.

The benefits of early, systematic rhythm control therapy were consistent regardless of whether patients had asymptomatic or symptomatic AF, according to new data from the EAST-AFNET 4 trial.

Rhythm control with early ablation or antiarrhythmic drugs in patients with symptomatic untreated paroxysmal AF.

Cryoballoon ablation was associated with significant improvement over antiarrhythmic drugs as a first-line intervention in preventing atrial fibrillation events, according to the results of the EARLY-AF trial.

In the past 5 years, we have witnessed a sharp decline in the number of cardiology fellows who have chosen to pursue advanced training in cardiac electrophysiology. What are the causes for this fall in interest?

The debate on the use of catheter ablation in patients with atrial fibrillation has intensified among cardiologists after results of the anticipated CABANA trial demonstrated that the procedure conferred better outcomes in patients with AF compared with medical therapy in per-protocol and on-treatment analyses, but not in an intention-to-treat analysis.

SAN ANTONIO — Several studies on SGLT2 inhibitors have shown that they may be able to reduce HF in patients with diabetes, according to a presentation at the American Society for Preventive Cardiology Congress on CVD Prevention.